Charles Hank Adelmann, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanosomes | 1 | 2020 | 33 | 0.740 |
Why?
|
Cysteine | 1 | 2020 | 891 | 0.520 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2021 | 4026 | 0.510 |
Why?
|
Lysosomes | 1 | 2020 | 924 | 0.490 |
Why?
|
Skin Neoplasms | 6 | 2021 | 5821 | 0.430 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1246 | 0.380 |
Why?
|
MAP Kinase Signaling System | 2 | 2016 | 1486 | 0.340 |
Why?
|
Protein Kinase Inhibitors | 2 | 2016 | 5671 | 0.340 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2016 | 2057 | 0.320 |
Why?
|
Genomics | 4 | 2022 | 5821 | 0.290 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3617 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3639 | 0.280 |
Why?
|
Genome, Human | 2 | 2021 | 4425 | 0.270 |
Why?
|
Membrane Proteins | 1 | 2020 | 7856 | 0.220 |
Why?
|
Oximes | 2 | 2016 | 303 | 0.220 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.210 |
Why?
|
Culture Media | 2 | 2021 | 897 | 0.200 |
Why?
|
Biomarkers, Pharmacological | 1 | 2022 | 161 | 0.190 |
Why?
|
Drug Compounding | 1 | 2022 | 246 | 0.190 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13639 | 0.180 |
Why?
|
Cystinosis | 1 | 2020 | 26 | 0.180 |
Why?
|
Activating Transcription Factor 4 | 1 | 2021 | 84 | 0.180 |
Why?
|
Cystine | 1 | 2020 | 94 | 0.180 |
Why?
|
Cell Fractionation | 1 | 2020 | 251 | 0.180 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2021 | 302 | 0.180 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 372 | 0.170 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12690 | 0.160 |
Why?
|
Imidazoles | 2 | 2016 | 1180 | 0.160 |
Why?
|
Melanins | 1 | 2020 | 290 | 0.160 |
Why?
|
Proteoglycans | 1 | 2021 | 803 | 0.150 |
Why?
|
Cell Line, Tumor | 7 | 2023 | 16981 | 0.150 |
Why?
|
GTP Phosphohydrolases | 1 | 2021 | 517 | 0.150 |
Why?
|
Mitochondria | 2 | 2021 | 3624 | 0.150 |
Why?
|
Ultraviolet Rays | 2 | 2020 | 1080 | 0.150 |
Why?
|
Epidermis | 1 | 2020 | 528 | 0.140 |
Why?
|
Indoles | 2 | 2016 | 1833 | 0.140 |
Why?
|
MAP Kinase Kinase 4 | 2 | 2013 | 149 | 0.140 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2016 | 38 | 0.130 |
Why?
|
Apoptosis | 4 | 2016 | 9486 | 0.130 |
Why?
|
Biological Transport | 1 | 2020 | 2091 | 0.130 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 802 | 0.130 |
Why?
|
Keratosis, Actinic | 1 | 2016 | 72 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 976 | 0.130 |
Why?
|
Endoplasmic Reticulum | 1 | 2021 | 1134 | 0.130 |
Why?
|
Sulfonamides | 2 | 2016 | 1978 | 0.120 |
Why?
|
Azetidines | 1 | 2016 | 142 | 0.120 |
Why?
|
Carbamates | 1 | 2016 | 191 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 477 | 0.120 |
Why?
|
Cell Line | 2 | 2020 | 15601 | 0.120 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2231 | 0.120 |
Why?
|
Genetic Markers | 1 | 2020 | 2601 | 0.110 |
Why?
|
Neoplasms | 2 | 2022 | 22170 | 0.110 |
Why?
|
Pyrimidinones | 1 | 2016 | 385 | 0.110 |
Why?
|
Niacinamide | 1 | 2013 | 413 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6132 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 809 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1959 | 0.090 |
Why?
|
Phenylurea Compounds | 1 | 2013 | 529 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2016 | 3597 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4141 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2016 | 980 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2243 | 0.080 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2811 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3602 | 0.070 |
Why?
|
Piperidines | 1 | 2016 | 1656 | 0.070 |
Why?
|
Protein Kinases | 1 | 2013 | 1608 | 0.070 |
Why?
|
Mice, Hairless | 2 | 2016 | 39 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3816 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5315 | 0.060 |
Why?
|
Humans | 15 | 2023 | 761504 | 0.060 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2023 | 58 | 0.050 |
Why?
|
Antimycin A | 1 | 2021 | 31 | 0.050 |
Why?
|
Oligomycins | 1 | 2021 | 20 | 0.050 |
Why?
|
3-Hydroxyacyl CoA Dehydrogenases | 1 | 2021 | 59 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16591 | 0.050 |
Why?
|
eIF-2 Kinase | 1 | 2021 | 145 | 0.040 |
Why?
|
Nanomedicine | 1 | 2022 | 290 | 0.040 |
Why?
|
Signal Transduction | 3 | 2023 | 23445 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 519 | 0.040 |
Why?
|
NAD | 1 | 2023 | 614 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2021 | 557 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 784 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13380 | 0.040 |
Why?
|
Animals | 6 | 2023 | 168459 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2023 | 1803 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1718 | 0.030 |
Why?
|
raf Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10445 | 0.030 |
Why?
|
Mice | 4 | 2023 | 81525 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2013 | 255 | 0.020 |
Why?
|
Homeostasis | 1 | 2023 | 3323 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2023 | 3113 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4278 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2446 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5722 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7581 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3303 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4346 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2020 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4111 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7048 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8547 | 0.020 |
Why?
|
Cell Survival | 1 | 2013 | 5791 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11903 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4484 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9420 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13506 | 0.010 |
Why?
|
Female | 1 | 2016 | 392644 | 0.000 |
Why?
|